Cataract-microcornea syndrome

Cataract-microcornea syndrome is a rare genetic eye disorder characterized by the combination of congenital or early-onset cataracts (clouding of the lens) and microcornea (a corneal diameter smaller than 11 mm in adults or smaller than expected for age in children). The condition primarily affects the anterior segment of the eye. Microcornea may be present at birth, while cataracts can be congenital or develop during childhood. The cataracts are often bilateral and may vary in type, including total, zonular, or cerulean (blue-dot) cataracts. Some affected individuals may also have additional ocular features such as myopia, iris coloboma, or mild corneal opacity, though the syndrome is generally limited to the eye without systemic involvement. The syndrome has been linked to mutations in several genes involved in lens and anterior segment development, including CRYAA (alpha-crystallin A), CRYBB1 (beta-crystallin B1), and CRYGD (gamma-crystallin D), among others. These crystallin genes encode structural proteins essential for maintaining lens transparency. Mutations disrupt normal protein folding and lens fiber organization, leading to cataract formation and abnormal anterior segment development. Treatment is primarily surgical, involving cataract extraction when visual impairment is significant. Early intervention is particularly important in children to prevent amblyopia (lazy eye) and to optimize visual development. Following cataract surgery, optical correction with intraocular lens implantation, contact lenses, or glasses is typically required. Long-term ophthalmologic follow-up is essential to monitor for complications such as glaucoma or posterior capsule opacification. Genetic counseling is recommended for affected families to discuss recurrence risks and the variable expressivity observed within families.

Common questions about Cataract-microcornea syndrome